Malek Chamoun
Corporate Officer/Principal en SUNSHINE BIOPHARMA, INC. .
Fortuna: 29 859 $ al 30/04/2024
Perfil
Malek Chamoun is the founder and current President of Nora Pharma, Inc. which is founded in 2017.
He is currently the Chief Development Officer at Sunshine Biopharma, Inc. where he started in 2024.
Mr. Chamoun received his undergraduate degree from Hautes Etudes Commerciales in 2008.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 28/03/2024 | 37 000 ( 3.72% ) | 29 859 $ | 30/04/2024 |
Cargos activos de Malek Chamoun
| Empresas | Cargo | Inicio |
|---|---|---|
| SUNSHINE BIOPHARMA, INC. | Corporate Officer/Principal | 25/01/2024 |
Nora Pharma, Inc.
 Nora Pharma, Inc. Medical DistributorsDistribution Services Part of Sunshine Biopharma, Inc., Nora Pharma, Inc. is a Canadian company that sells generic drugs. The private company is based in Varennes, Canada. The company was founded in 2017 by Malek Chamoun. Nora Pharma was acquired by Sunshine Biopharma, Inc. on October 20, 2022 for $22.88 million. | Fundador | 01/01/2017 |
Formación de Malek Chamoun.
| Hautes Etudes Commerciales | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| SUNSHINE BIOPHARMA, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Nora Pharma, Inc.
Nora Pharma, Inc. Medical DistributorsDistribution Services Part of Sunshine Biopharma, Inc., Nora Pharma, Inc. is a Canadian company that sells generic drugs. The private company is based in Varennes, Canada. The company was founded in 2017 by Malek Chamoun. Nora Pharma was acquired by Sunshine Biopharma, Inc. on October 20, 2022 for $22.88 million. | Distribution Services |
- Bolsa de valores
- Insiders
- Malek Chamoun
